How big is the anti-inflammatory therapeutics market today, and what are its future growth expectations?
The anti-inflammatory therapeutics market size has grown steadily in recent years. It will grow from $114.71 billion in 2024 to $118.44 billion in 2025 at a compound annual growth rate (CAGR) of 3.3%. The growth in the historic period can be attributed to prevalence of chronic diseases, aging population, increased awareness, and government initiatives.
The anti-inflammatory therapeutics market size is expected to see strong growth in the next few years. It will grow to $144.05 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to innovative therapies, increasing healthcare expenditure, focus on rare diseases, biologics and biosimilars. Major trends in the forecast period include advancements in immunotherapy, artificial intelligence (AI) and machine learning (ML) in drug discovery, expansion of indications.
Get Your Free Sample of The Global Anti-Inflammatory Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp
What have been the primary factors driving the anti-inflammatory therapeutics market’s growth?
The increasing prevalence of inflammatory bowel disease is expected to propel the growth of the anti-inflammatory therapeutics market going forward. Inflammatory bowel disease (IBD) is a chronic illness resulting in inflammation of the gastrointestinal tract. Anti-inflammatory therapeutics play a crucial role in treating Crohn’s disease by reducing inflammation, managing the symptoms of the disease, and reducing the risk of surgery. For instance, in July 2023, according to Oxford University Press (OUP), the university press of the University of Oxford, incidence of inflammatory bowel disease (IBD) is 10.9 per 100,000 person-years and the prevalence is 721 per 100,000 people. Therefore, the increasing prevalence of inflammatory bowel disease is driving the growth of the anti-inflammatory therapeutics market.
What are the key segments within the anti-inflammatory therapeutics market?
The anti-inflammatory therapeutics market covered in this report is segmented –
1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics
2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen
2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone
3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Janus Kinase (JAK) Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins
Order your report now for swift delivery
Which key players are shaping the anti-inflammatory therapeutics market?
Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.
How will emerging trends drive the anti-inflammatory therapeutics market throughout the forecast period?
Major companies operating in the anti-inflammatory therapeutics market are introducing innovative drugs to strengthen their position in the market. For instance, in February 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, and Sanofi, a France-based pharmaceutical and healthcare company, launched Kevzara (sarilumab). The first and only anti-inflammatory biologic recommended for adult patients with polymyalgia rheumatic (PMR), an inflammatory rheumatic condition, who don’t respond adequately to corticosteroids or cannot endure corticosteroid tapering.
How do regional factors impact the anti-inflammatory therapeutics market, and which region is the largest contributor?
North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Does The Anti-Inflammatory Therapeutics Market Report 2025 Offer?
The anti-inflammatory therapeutics market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Anti-inflammatory therapeutics refer to prescription medications that treat pain, lessen inflammation, and lower a high body temperature. It acts as a host response modifier and plays a crucial role in managing acute and chronic headaches, painful phases, sprains, and strain problems.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12861
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
